Security key
89455T109
TREACE MEDICAL CONCEPTS, INC. - Common Stock (TMCI)
CUSIP: 89455T109
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 20,370,513
- Total 13F value
- $385,285,843
- Share change
- +2,022,346
- Put/Call ratio
- 4.3%
- SEC-reported price per share
- $18.91
- Number of holders
- 74
- Value change
- +$38,473,149
- Number of buys
- 40
- Number of sells
- 39
- Shares outstanding
- 63,954,667
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
74
Top holders
10
TMCI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
TREACE MEDICAL CONCEPTS, INC. SEC filings
TREACE MEDICAL CONCEPTS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89455T109
Recent filing periods:
Ownership snapshot
Top reported holders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CIBC Private Wealth Group...
Disclosed value leader
CIBC Private Wealth Group...
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F
Lead comparable stake: 19%
Showing 1-6 of 15 holder rows.
Quick read
CIBC Private Wealth Group LLC leads the comparable SEC ownership view at 19%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CIBC Private Wealth Group LLC's linked filing trail.
Comparable ownership
Top 5
CIBC Private Wealth Group LLC
19%
ALLIANCEBERNSTEIN L.P.
3.8%
VANGUARD GROUP INC
3.6%
NEXT CENTURY GROWTH INVESTORS LLC
2.4%
BlackRock Finance, Inc.
2.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CIBC Private Wealth Group LLC |
13F
Company
|
19%
|
$110,070,000
11,994,578 shares
|
— | 31 Dec 2021 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
3.8%
|
$45,759,000
2,454,893 shares
|
— | 31 Dec 2021 |
| VANGUARD GROUP INC |
13F
Company
|
3.6%
|
$42,421,000
2,275,779 shares
|
— | 31 Dec 2021 |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
Company
|
2.4%
|
$28,623,000
1,535,610 shares
|
— | 31 Dec 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
2.4%
|
$28,310,000
1,518,826 shares
|
— | 31 Dec 2021 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
1.5%
|
$18,271,000
980,186 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
74
Shares
20,370,513
Rows available
74
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q3 2025 Across Filers
Q3 2025 holders
117
Q1 2022 holders
74
Holder diff
-43
| Investor | Q3 2025 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend